Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma
暂无分享,去创建一个
M. Kudo | Y. Minami | S. Kitai | Tatsuo Inoue | S. Hagiwara | K. Ueshima | T. Sakurai | Masashi Kono | T. Arizumi | N. Nishida | M. Takita | N. Yada | Hirokazu Chishina | H. Chishina